Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Mark Hillier has worked on the following 22 EPO patent applications which have been published in the last five years:

EP12706858

QUINOLINONE DERIVATIVES

IPC classification:
A61K 31/47, A61K 31/4709, A61P 3/10, A61P 9/10, A61P 25/16, A61P 25/28, C07D 215/20, C07D 215/36, C07D 401/04, C07D 401/10, C07D 401/14, C07D 409/14, C07D 413/04, C07D 413/14, C07D 417/04, C07D 417/10, C07D 417/14
Applicant:
GlaxoSmithKline LLC
Agent:
Mark Hillier, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12738141

HETEROCYCLYL PYRIMIDINE ANALOGUES AS JAK INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00, C07D 403/12, C07D 491/10
Applicant:
Cellzome Ltd
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762577

PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 37/06, C07D 471/04, C07D 487/04
Applicant:
Cellzome Ltd
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11722343

PYRROLO [3, 2 -D]PYRIMIDIN-3 -YL DERIVATIVES USED AS ACTIVATORS OF AMPK

IPC classification:
A61K 31/519, A61P 3/04, A61P 3/10, A61P 9/00, A61P 9/10, A61P 35/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12800913

TRPV4 ANTAGONISTS

IPC classification:
A61K 31/422, A61P 9/04, C07D 413/08, C07D 413/14
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12814591

TRPV4 ANTAGONISTS

IPC classification:
C07D 263/52, C07D 419/14, C07D 498/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12806057

PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/506, A61P 35/00, A61P 37/00, C07D 403/14
Applicant:
Cellzome Ltd
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12797080

NOVEL COMPOUNDS

IPC classification:
A01N 43/42, A61K 31/437, A61P 25/28, C07D 401/00, C07D 471/04, C07D 519/00
Applicant:
GlaxoSmithKline Intellectual Property Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11714581

PYRAZOLE COMPOUNDS AS JAK INHIBITORS

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, C07D 487/04
Applicant:
Cellzome Ltd
Agent:
Edwin Büchel, Isenbruck Bösl Hörschler LLP
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13738099

THERAPEUTIC USES

IPC classification:
A61K 31/4174, A61K 31/4245, A61K 31/445, A61K 31/4545, A61K 31/501, A61K 31/55, A61P 25/00, C07D 211/14, C07D 223/16, C07D 233/64, C07D 237/14, C07D 317/48, C07D 401/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12801296

TRPV4 ANTAGONISTS

IPC classification:
A61K 31/423, A61P 9/10, C07D 413/08
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
PATENT GRANTED
EP12706859

1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES

IPC classification:
A61K 31/519, A61P 3/00, A61P 9/00, A61P 35/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13724816

HETEROCYCLYL PYRIMIDINE ANALOGUES AS TYK2 INHIBITORS

IPC classification:
A61K 31/505, A61P 37/00, C07D 401/14, C07D 403/12, C07D 405/14, C07D 413/14
Applicant:
Cellzome Ltd
Agent:
Mark Hillier, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15166109

PYRIDINYL- AND PYRAZINYL -METHYLOXY - ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)

IPC classification:
A61K 31/47, A61P 37/00, C07D 401/12, C07D 403/12
Applicant:
Glaxo Group Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11733258

COMPOUNDS AND METHODS

IPC classification:
A01N 43/54, A61P 9/04
Applicant:
GlaxoSmithKline LLC
Agent:
Mark Hillier, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11757574

2-(BENZYLOXY)BENZAMIDES AS LRRK2 KINASE INHIBITORS

IPC classification:
A61K 31/42, A61K 31/4406, A61K 31/4439, A61K 31/4545, A61K 31/501, A61K 31/5377, C07C 235/64, C07D 213/75, C07D 231/12, C07D 237/22, C07D 261/14, C07D 295/192, C07D 401/12, C07D 403/12, C07D 413/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11706815

Morpholino substituted urea derivatives as mtor inhibitors

IPC classification:
A61K 31/5377, A61P 37/00, C07D 239/42, C07D 401/04, C07D 413/04, C07D 413/14, C07D 498/08
Applicant:
Cellzome Ltd
Agent:
Edwin Büchel, Isenbruck Bösl Hörschler LLP
Agent:
Mark Hillier, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11760129

TRPV4 ANTAGONISTS

IPC classification:
A61K 31/47, A61P 9/00, A61P 13/10, C07D 401/06, C07D 401/14
Applicant:
GlaxoSmithKline LLC
Agent:
Mark Hillier, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14818951

3-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL)PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS

IPC classification:
A61K 31/423, A61K 31/4439, A61K 31/501, A61K 31/506, A61P 25/00, C07D 263/58, C07D 413/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
The patent has been granted
EP15743797

COMPOUNDS

IPC classification:
A61K 31/519, A61P 25/16, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15743645

COMPOUNDS

IPC classification:
A61K 31/437, A61K 31/4375, A61P 25/16, C07D 403/00, C07D 403/02, C07D 487/00, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15720312

A PRODRUG OF 1,1'-(1,6-DIOXO-1,6-HEXANEDIYL)BIS-D-PROLINE

IPC classification:
A61K 31/4025, A61P 25/28, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Mark Hillier, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature